Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ingram Micro Inc.
Ingram Micro Updates Third Quarter Outlook
October 5th, 2008
Ingram Micro Inc. (NYSE:IM), the world's largest technology distributor, issued a revised financial outlook for the third quarter ending September 27, 2008. Revenues for the third quarter now are expected to range from $8.3 billion to $8.6 billion. Net income is expected to range from $30 million to $39 million, or $0.18 to $0.23 per diluted share based on 169 million weighted average shares outstanding. This includes an estimated $5 million ($3 million net of tax or $0.02 per diluted share) in costs to be incurred during the third quarter related to the completion of expense-reduction plans in North America and Europe. "Earlier this month, we...
Source: Pharma Investments, Ventures & Law Weekly (2008-10-05)
|
